Edmonston, Daniel http://orcid.org/0000-0003-2589-6993
Grabner, Alexander http://orcid.org/0000-0002-5544-1896
Wolf, Myles http://orcid.org/0000-0002-1127-1442
Article History
Accepted: 13 June 2023
First Online: 13 July 2023
Competing interests
: M.W. has equity interests in Akebia, Unicycive and Walden, and has served as a consultant for Bayer, Enyo, Jnana, Launch, Pharmacosmos and Reata. The other authors declare no competing interests.